INTRODUCTION: Nonunion is a challenging condition in orthopaedics as its etiology is not fully understood. Clinical interventions currently aim to stimulate both the biological and mechanical aspects of the bone healing process by using bone autografts and surgical fixation. However, recent observations showed that atrophic nonunion tissues contain putative osteoprogenitors, raising the hypothesis that its reactivation could be explored to achieve bone repair. METHODS: Here we characterized atrophic nonunion stromal cells (NUSC) in vitro, using bone marrow stromal cells (BMSC) and osteoblasts as controls cells of the osteoblastic lineage, and evaluated its ability to form bone in vivo. RESULTS: NUSC had proliferative and senescence rates comparable to BMSC and osteoblasts, and homogeneously expressed the osteolineage markers CD90 and CD73. Regarding CD105 and CD146 expression, NUSC were closely related to osteoblasts, both with an inferior percentage of CD105+/CD146+ cells as compared to BMSC. Despite this, NUSC differentiated along the osteogenic and adipogenic lineages in vitro; and when transplanted subcutaneously into immunocompromised mice, new bone formation and hematopoietic marrow were established. CONCLUSIONS: This study demonstrates that NUSC are osteogenically competent, supporting the hypothesis that their endogenous reactivation could be a strategy to stimulate the bone formation while reducing the amount of bone autograft requirements.
INTRODUCTION: Nonunion is a challenging condition in orthopaedics as its etiology is not fully understood. Clinical interventions currently aim to stimulate both the biological and mechanical aspects of the bone healing process by using bone autografts and surgical fixation. However, recent observations showed that atrophic nonunion tissues contain putative osteoprogenitors, raising the hypothesis that its reactivation could be explored to achieve bone repair. METHODS: Here we characterized atrophic nonunion stromal cells (NUSC) in vitro, using bone marrow stromal cells (BMSC) and osteoblasts as controls cells of the osteoblastic lineage, and evaluated its ability to form bone in vivo. RESULTS: NUSC had proliferative and senescence rates comparable to BMSC and osteoblasts, and homogeneously expressed the osteolineage markers CD90 and CD73. Regarding CD105 and CD146 expression, NUSC were closely related to osteoblasts, both with an inferior percentage of CD105+/CD146+ cells as compared to BMSC. Despite this, NUSC differentiated along the osteogenic and adipogenic lineages in vitro; and when transplanted subcutaneously into immunocompromised mice, new bone formation and hematopoietic marrow were established. CONCLUSIONS: This study demonstrates that NUSC are osteogenically competent, supporting the hypothesis that their endogenous reactivation could be a strategy to stimulate the bone formation while reducing the amount of bone autograft requirements.
Authors: Thomas A St John; Alexander R Vaccaro; Alexander P Sah; Marcia Schaefer; Scott C Berta; Todd Albert; Alan Hilibrand Journal: Am J Orthop (Belle Mead NJ) Date: 2003-01
Authors: Joseph Borrelli; Chris Pape; David Hak; Joseph Hsu; Sheldon Lin; Peter Giannoudis; Joseph Lane Journal: J Orthop Trauma Date: 2012-12 Impact factor: 2.512
Authors: D S Elliott; K J H Newman; D P Forward; D M Hahn; B Ollivere; K Kojima; R Handley; N D Rossiter; J J Wixted; R M Smith; C G Moran Journal: Bone Joint J Date: 2016-07 Impact factor: 5.082
Authors: Rozalia Dimitriou; Ian M Carr; Robert M West; Alexander F Markham; Peter V Giannoudis Journal: BMC Musculoskelet Disord Date: 2011-02-10 Impact factor: 2.362
Authors: Michalis Panteli; James S H Vun; Ippokratis Pountos; Anthony J Howard; Elena Jones; Peter V Giannoudis Journal: J Cell Mol Med Date: 2022-01-04 Impact factor: 5.310